RECRUITINGINTERVENTIONAL
Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome
Efficacy of Restoration of Lacrimal Secretion After Injection of Platelet-Rich Plasma (PRP) Into the Lacrimal Gland in Severe Dry Eye Syndromes (ReLIPSSO)
About This Trial
The investigatror wants to show the efficacy of Platelet-Rich Plasma injection in lacrimal gland to restore the lacrimal secretion in patients presenting aqueous deficiency reponsible for severe dry eye syndrome.
Who May Be Eligible (Plain English)
Who May Qualify:
- Platelet counts, and clotting factors in the standarts
- Presenting with severe dry keratoconjunctivitis diagnosed by an ophthalmologist
Who Should NOT Join This Trial:
- Patients with significant fibrosis of the conjunctival portion of the lacrimal gland
- Patients with complete stenosis of both lacrimal meatus in the treated eye
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Platelet counts, and clotting factors in the standarts
* Presenting with severe dry keratoconjunctivitis diagnosed by an ophthalmologist
Exclusion Criteria:
* Patients with significant fibrosis of the conjunctival portion of the lacrimal gland
* Patients with complete stenosis of both lacrimal meatus in the treated eye
Treatments Being Tested
OTHER
injections of Platelet-Rich Plasma in lacrimal gland
injections of Platelet-Rich Plasma in lacrimal gland
Locations (1)
CHU de Nice
Nice, Site Principal Investigator, France